This inventor holds 1 USPTO granted patent. Top assignee: The General Hospital Corporation. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Alan H Gorn: Innovator in Nucleic Acid Research
Introduction
Alan H Gorn is a notable inventor based in Boston, MA. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acids. His work has implications for understanding and utilizing calcitonin receptors, which are crucial in various biological processes.
Latest Patents
Alan H Gorn holds a patent for "Nucleic acids encoding calcitonin receptor and uses thereof." This patent describes recombinant DNA that encodes a calcitonin receptor polypeptide, vectors and hosts containing the recombinant DNA, and methods for expressing a calcitonin receptor polypeptide from the recombinant DNA. This innovation has the potential to advance research and therapeutic applications related to calcitonin receptors.
Career Highlights
Gorn is affiliated with The General Hospital Corporation, where he has been involved in groundbreaking research. His work has contributed to the understanding of receptor biology and its applications in medicine. With 1 patent to his name, he has established himself as a key figure in his field.
Collaborations
Throughout his career, Alan has collaborated with esteemed colleagues such as Steven R Goldring and Herb Y Lin. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Alan H Gorn's contributions to nucleic acid research and his innovative patent highlight his role as a significant inventor in the field. His work continues to influence advancements in molecular biology and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
